Insider at

04

Insider transactions

05
0 buys (P) 0 sells (S) Net: $0 + 7 non-open-market transactions below last 12 months, based on the transactions shown below

Price change vs current quote, split-adjusted for corporate actions since the filing — not benchmarked, not annualized, not size-weighted

7 other filings hidden
DateTickerCodeSharesPriceValue Owned afterΔ ownA/Dvs now
Dec. 2, 2013 MED S 18,000 $25.63 $461,340 396,597 Indirect -4.34% Disposed -54.2% (price as of 2026-10-02)
Nov. 22, 2013 MED S 8,000 $26.01 $208,080 414,597 Indirect -1.89% Disposed -54.9% (price as of 2026-10-02)
Nov. 8, 2013 MED S 20,000 $23.84 $476,800 422,597 Indirect -4.52% Disposed -50.8% (price as of 2026-10-02)
Nov. 7, 2013 MED S 7,000 $23.83 $166,810 442,597 Indirect -1.56% Disposed -50.8% (price as of 2026-10-02)

P = Open-market purchase · S = Sale · A = Grant/award · M = Option exercise · G = Gift · F = Tax withholding

Insider transactions are not a recommendation; sales are often driven by liquidity or tax reasons.

Derivative holdings (Form 4 Table II) Options, RSUs and convertible securities reported on Form 4 Table II.

06
DateTickerSecurityUnderlying Exercise priceExpirationSharesA/D
Feb. 5, 2014 MED Stock Options Common Stock (2,000) $26.52 Feb. 5, 2024 2,000 Acquired
Feb. 19, 2013 MED Stock Options Common Stock (2,000) $24.26 Feb. 19, 2023 2,000 Acquired

Exercise/conversion price is blank when not applicable (e.g. RSUs).

Initial ownership (Form 3) 3 holdings

07

Securities held when first becoming an insider, per SEC Form 3.

DateTickerSecuritySharesOwnership
Dec. 3, 2014 MED Common Stock 2,681 Direct
Dec. 3, 2014 MED Common Stock 449,597 Indirect
May 28, 2013 MED Common Shares 2,586 Direct